might have been leaked...or the guesses were right on the money.The Nimo prognosis looks great.
and Castro's son from cuba visiting u.s.
goodness....387 alone could justify a stock price of $5 today...what is nimo worth now?? And how about the vascular disruptive agent in the pipeline.I've said Amgen, J&J, BMS, Celgene and Pfizer all could be great partners. But why leave Japanese pharma out of the mix...how about Daiichi?
Takeda and Astellas are big in Onco. I think mgmt wants to hold on to this jewel for as long as they could bear the grumblings from impatient stockholders.
Can nimo be licensed in the US ?